ClearPoint Neuro

CLPT · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

6

Q3 2025

Reported

Reported earnings 3 months ago

Total Revenue

$8.86M

Previous year: $8.12M

+9.1%

EPS

-$0.21

Previous year: -$0.18

Previous year: $4.85M

+15.5%

Cash and Equivalents

$38.2M

Previous year: $21.6M

+76.9%

Total Assets

$60.4M

Previous year: $40.2M

+50.2%

Loading...

ClearPoint Neuro

Unlock previous datapoints

Upgrade

ClearPoint Neuro

Unlock previous datapoints

Upgrade

ClearPoint Neuro Revenue by Segment

Revenue by Segment

Biologics and Drug Delivery Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Neurosurgery Navigation and Therapy Revenue

CapyFin.com

Capital Equipment and Software Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$385M

P/E Ratio

-15.49

Sector

N/A

Industry

N/A

52-Week High

$29.5

52-Week Low

$9.98

Gross Margin

63%

Products

Get in Touch

Resources

ClearPoint Neuro

ClearPoint Neuro

ClearPoint Neuro

ClearPoint Neuro Revenue by Segment

Revenue by Segment

Biologics and Drug Delivery Revenue

Neurosurgery Navigation and Therapy Revenue

Capital Equipment and Software Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics